Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAquis Exchange Regulatory News (AQX)

  • This share is currently suspended. It was suspended at a price of 725.00
  • There is currently no data for AQX

Director/PDMR Dealing

4 Apr 2022 07:00

RNS Number : 0290H
Aquis Exchange PLC
04 April 2022
 

4 April 2022

Aquis Exchange PLC

("Aquis" or the "Company")

Director/PDMR Dealing

Aquis Exchange PLC (AQX.L), the exchange services group, announces that it has received notification that Glenn Collinson, Independent Non-Executive Chairman of the Company, has purchased a total of 12,003 ordinary shares of 10p each in the Company ("Ordinary Shares") at an average price of £5.12 per Ordinary Share.

Following the purchase, Mr Collinson is now interested in 12,003 Ordinary Shares, representing 0.04% of the Company's issued share capital.

Enquiries:

Aquis Exchange PLC

Tel: +44 (0) 7768 078 110

Belinda Keheyan, Head of Marketing

 

VSA Capital Limited (AQSE Corporate Adviser)

Tel: +44(0) 20 3005 5000

Andrew Raca

Pascal Wiese

 

Liberum Capital Limited (Nominated Adviser and Joint Broker)

Tel: +44 (0) 20 3100 2000

Chris Clarke

Clayton Bush

Edward Thomas

Kane Collings

 

Canaccord Genuity Limited (Joint Broker)

Tel: +44 (0) 20 7523 8000

Bobbie Hilliam

Patrick Dolaghan

 

Alma PR (Financial PR Adviser)

Tel: +44 (0)20 3405 0209

Susie Hudson

aquis@almapr.co.uk

Kieran Breheny

Matthew Young

 

Notes to Editors

About Aquis Exchange

Aquis Exchange PLC is an exchange services group, which operates pan-European cash equities trading businesses (Aquis Exchange), growth and regulated primary markets (Aquis Stock Exchange/AQSE) and develops/licenses exchange software to third parties (Aquis Technologies).

Aquis Exchange is authorised and regulated by the UK Financial Conduct Authority and France's Autorité des Marchés Financiers to operate Multilateral Trading Facility businesses in the UK/Switzerland and in EU27 respectively. Aquis operates lit order books and does not allow aggressive non-client proprietary trading, which has resulted in lower market impact and signalling risk on Aquis than other trading venues in Europe. According to independent studies, trades on Aquis are less likely to lead to price movement than on other lit markets. Aquis uses a subscription pricing model which works by charging users according to the message traffic they generate, rather than a percentage of the value of each stock that they trade.

Aquis Stock Exchange (AQSE) is a stock market providing primary and secondary markets for equity and debt products. It is authorised as a Recognised Investment Exchange, which allows it to operate a regulated listings venue. The AQSE Growth Market is divided into two segments 'Access' and 'Apex', with different levels of admission criteria. The Access market focuses on earlier stage growth companies, while Apex is the intended market for larger, more established businesses.

Aquis Technologies is the software and technology division of Aquis Exchange PLC. It creates and licenses cutting-edge, cost-effective matching engine and trade surveillance technology for banks, brokers, investment firms and exchanges.

Aquis Exchange PLC (AQX.L) is listed on the Alternative Investment Market of the LSE (AIM) market. For more information, please go to www.aquis.eu

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Name

Glenn Collinson

2.

Reason for the notification

b)

Position / status

Independent Non-Executive Chairman

c)

Initial notification / amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Aquis Exchange PLC

b)

LEI

213800IXJSF5E1SIW150

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Identification Code

Ordinary Shares of 10p each 

 

GB00BD5JNK30

b)

Nature of the transaction

Purchase of shares

c)

Price(s) and volume(s)

 

 

Price

Volume

Date

Exchange

£5.3

6000

30-03-2022

AIM

£4.942857

199

31-03-2022

AIM

£4.942857

402

31-03-2022

AIM

£4.942857

402

31-03-2022

AIM

£4.942857

1000

31-03-2022

AIM

£4.94

1000

31-03-2022

AIM

£4.95

3000

31-03-2022

AQSE

 

d)

Aggregated information

Aggregated volume

Price

12,003 Ordinary Shares purchased at an average price of £5.1229326 for consideration of £61,490.56 on 30 and 31 March 2022

e)

Date of the transaction

30 and 31 March 2022

f)

Place of the transaction

London Stock Exchange (AIM) and AQSE

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHEASLFEFEAEFA
Date   Source Headline
20th Nov 202412:03 pmRNSForm 8.3 - Aquis Exchange PLC
20th Nov 202411:52 amRNSForm 8 (OPD) - Aquis Exchange PLC
20th Nov 202411:21 amRNSForm 8.3 - Aquis Exchange plc
20th Nov 202410:38 amRNSForm 8.5 (EPT/RI)
20th Nov 20249:27 amRNSForm 8.3 - Aquis Exchange PLC
20th Nov 20249:27 amRNSForm 8.3 - Aquis Exchange PLC
20th Nov 20249:25 amRNSForm 8.3 - Aquis Exchange PLC
20th Nov 20247:00 amRNSForm 8 (OPD) - Aquis Exchange PLC
20th Nov 20246:55 amGNWForm 8.5 (EPT/RI)-Aquis Exchange plc
19th Nov 20247:00 amRNSDirectorate Change
18th Nov 20244:10 pmRNSBlock Listing Six Monthly Return
18th Nov 202411:33 amRNSForm 8.3 - Aquis Exchange PLC
18th Nov 202411:29 amRNSForm 8.3 - Aquis Exchange PLC
18th Nov 202411:28 amRNSForm 8.3 - Aquis Exchange PLC
18th Nov 202411:24 amRNSForm 8.3 - Aquis Exchange PLC
18th Nov 202411:24 amRNSForm 8.3 - Aquis Exchange PLC
18th Nov 202411:21 amRNSForm 8.3 - Aquis Exchange PLC
18th Nov 202411:18 amRNSForm 8.3 - Aquis Exchange PLC
18th Nov 202411:16 amRNSForm 8.3 - Aquis Exchange PLC
14th Nov 20244:02 pmBUSForm 8.3 - Aquis Exchange PLC - Opening Disclosure
14th Nov 20249:52 amRNSForm 8.5 (EPT/RI)
14th Nov 20247:49 amGNWForm 8.5 (EPT/RI)-Aquis Exchange Plc
13th Nov 20241:17 pmEQSForm 8.3 - Apex Fundrock Limited : Form 8.3 - Aquis Exchange PLC
13th Nov 202411:04 amRNSForm 8.5 (EPT/RI)
13th Nov 20249:35 amRNSForm 8.5 (EPT/RI)
13th Nov 20249:10 amGNWForm 8.5 (EPT/RI) - Aquis Exchange Plc
12th Nov 20242:40 pmPRNForm 8.3 - Aquis Exchange PLC
12th Nov 20241:24 pmRNSForm 8.3 - AQUIS EXCHANGE PLC
12th Nov 20241:05 pmGNWForm 8.3 - [AQUIS EXCHANGE PLC - Opening Disclosure - 11 11 2024] - (CGAML)
12th Nov 202412:20 pmRNSForm 8.3 - Aquis Exchange plc
12th Nov 202412:12 pmRNSForm 8.3 - Aquis Exchange PLC
12th Nov 202411:49 amRNSForm 8.3 - Aquis Exchange plc
12th Nov 202410:51 amGNWForm 8.3 - AXA INVESTMENT MANAGERS: Aquis Exchange plc
12th Nov 202410:32 amRNSForm 8.5 (EPT/RI)
12th Nov 202410:20 amBUSForm 8.3 - Aquis Exchange plc
12th Nov 20249:51 amRNSForm 8.5 (EPT/RI)
12th Nov 20248:40 amGNWForm 8.5 (EPT/RI) - Aquis Exchange Plc
11th Nov 20241:05 pmRNSRule 2.9 Announcement
11th Nov 202410:45 amRNSForm 8.3 - Aquis Exchange PLC
11th Nov 20247:00 amRNSOffer for Aquis Exchange PLC
19th Sep 20246:26 pmRNSHolding(s) in Company
19th Sep 20247:00 amRNSDirector/PDMR Shareholding
12th Sep 20247:00 amRNSInterim Results
28th Aug 20247:00 amRNSTrading Update and Notice of Results
17th May 20247:00 amRNSBlock listing application
18th Apr 20242:30 pmRNSResult of AGM and Confirmation of Board Change
22nd Mar 20247:00 amRNSPublication of Annual Report and Notice of AGM
21st Mar 20247:00 amRNSResults for the year ended 31 December 2023
13th Mar 20247:00 amRNSContract with the Central Bank of Colombia
12th Mar 20247:00 amRNSAquis to Establish New Real Assets Market Segment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.